TheEdgeResearch
Home / Stocks / RWBYF

Red White & Bloom Brands Inc. (RWBYF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.03 ▲ +1.82%
Market Cap
$13.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.55
52-Wk Range
1.0E-4-0.1446
CEO
Brad Rogers
Country
CA
Currency
USD

Red White & Bloom Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.03, up 1.82% on the session, giving a market capitalisation of $13.7M. On trailing twelve-month figures it carries a trailing P/E of -0.10, a net margin of -150.7%. Its beta of 0.55 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.10
Price / Sales
0.16
Price / Book
-0.04
EV / EBITDA
-28.46
Gross margin
20.7%
Operating margin
-32.5%
Net margin
-150.7%
Return on equity
Debt / equity
-1.81
Current ratio
0.78
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2021-01-08
Headquarters
Vancouver, BC, CA
About Red White & Bloom Brands Inc.

Red White & Bloom Brands Inc. operates within the cannabis industry, focusing on both the cultivation and retail sale of its various products. The company's primary market presence is concentrated in the U.S. states of Michigan, California, Florida, and Oklahoma. Its corporate headquarters are located in Vancouver, Canada.

Comparable companies

Red White & Bloom Brands Inc. is most often compared with the following Healthcare names:

BFFTFCNPOFHMPSFMGCLFMRVFFNXTTFPKANFRAMMFRXMDTMDIF
More research on RWBYF
RWBYF technical analysis RWBYF TheEdge Score Compare against peers
Open full interactive analysis & DCF →